phosphoserine has been researched along with ketamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beurel, E; Jope, RS; Song, L | 1 |
| Hsieh, WK; Keng, NT; Lai, CC; Lin, HH; Lin, HR | 1 |
2 other study(ies) available for phosphoserine and ketamine
| Article | Year |
|---|---|
Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice.
Topics: Amino Acid Substitution; Animals; Antidepressive Agents; Cerebral Cortex; Depression; Disease Models, Animal; Drug Evaluation, Preclinical; Electroshock; Gene Knock-In Techniques; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Helplessness, Learned; Hippocampus; Ketamine; Lithium Chloride; Mice; Nerve Tissue Proteins; Phosphorylation; Phosphoserine; Point Mutation; Protein Processing, Post-Translational | 2011 |
Dual regulation by ethanol of the inhibitory effects of ketamine on spinal NMDA-induced pressor responses in rats.
Topics: Animals; Blotting, Western; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Ethanol; Injections, Spinal; Ketamine; Male; N-Methylaspartate; Phosphorylation; Phosphoserine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spinal Cord; Thionucleotides; Time Factors | 2012 |